Prise en charge de l’infection par les virus des hépatites B ou C chez l’insuffisant rénal chronique

Vallet-Pichard, Anaı̈s; Pol, Stanislas

doi:10.1016/j.nephro.2015.06.002

Cited by 3 publications

(2 citation statements)

References 132 publications

(189 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our series, the median duration is 7 years, with a risk multiplied by 1. 16 for each year in hemodialysis more. Seniority in hemodialysis is a major risk factor for hemodialysis patients.…”

Section: Discussionmentioning

confidence: 99%

“…This can be explained by taking the following steps: -serological screening of anti-HCV antibodies in blood donors, established since 1994 -the use of erythropoietin to treat anemia secondary to renal failure -the respect of the rules of universal hygiene: The human factor constitutes an angular piece in the transversal transmission of the virus in the centers of hemodialysis. Medical and paramedical personnel must be made aware of the respect of universal hygiene measures in order to avoid the transmission of HCV by hands, instruments soiled with blood and untimely manipulation [16,17].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Seroprevalence of Hepatitis C in Chronic Hemodialysis Patients in Marrakesh Region

Arsalane¹

2019

AJLM

View full text Add to dashboard Cite

Infection with the hepatitis C virus (HCV) is a major global public health problem. The objectives of this study are to evaluate the seroprevalence of hepatitis C in chronic hemodialysis patients, a category of patients at particular risk of hepatitis C virus transmission, and to identify the main risk factors for infection. This is a prospective study conducted from January 1st, 2015 to December 31st, 2017, including 600 chronic hemodialysis patients treated at 5 centers in the Marrakech region. Patients were tested for anti-HCV antibodies by chemiluminescent microparticulate immunoassay (CMIA). The confirmation is carried out by ELISA. The statistical analysis was performed using the SPSS statistics 17.0 software. The prevalence of anti-HCV antibodies is 15%. There is no statistically significant difference between the groups of HCV-infected and non-HCV-infected patients in terms of age, sex, and number of RBCs transfused. In contrast, the median hemodialysis duration and the number of attended hemodialysis centers were significantly higher in the HCV + group (p <0.001). The factor transfusion long incriminated, loses its importance. On the other hand, seniority in hemodialysis and the number of centers frequented seem to be contributing factors. Adherence to hygiene measures and the rigorous application of prevention recommendations against HCV transmission could further improve the prevalence of hepatitis C in dialysis units.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%